lebih tinggi dari kelompok MAN (74,33 ± 6,18 mmHg) (p = 0,002). Relaksasi otak pada kedua kelompok tidak berbeda bermakna (p = 0,988) . Glukosa darah meningkat secara bermakna pada kelompok SLH (17,95 ± 11,46 mg/dL; p = 0,001 
Mannitol has been used as the standard and recommended hyperosmotic agent to provide brain relaxation. [1] [2] [3] [4] Nevertheless, the use of mannitol is associated with several side effects, such as hypotension, hypovolemia, hyponatremia, and renal failure. [5] [6] [7] Two studies comparing the effects of mannitol and hypertonic saline (HTS) on brain relaxation have suggested that HTS is as effective as and better than mannitol in providing brain relaxation. [7] [8] However, the presence of nonmetabolized chloride anion (Cl -) in HTS may have a detrimental effect. The equivalent load of sodium (Na + ) and Cl -from HTS infusion will decrease the strong ion difference (SID) and in turn increases the degree of water dissociation, and finally results in metabolic acidosis. 9 Lactate is now recognized as a key inter-cellular metabolite between glycolysis and oxidative phosphorylation that can be both produced and utilized by the brain under pathological conditions. 10 Animal and human studies showed that lactate can prevent the detrimental neurological effect of hypoglycemia, indicating that systemic lactate can be metabolized by the brain. 11 Experimental data on rat hippocampi submitted to an ischemia reperfusion injury found that lactate was a better substrate than glucose. 12 Hypertonic sodium lactate (HSL) solution has currently been an interesting alternative both as a resuscitation fluid and osmotherapy. A study comparing the efficacy of HSL and mannitol in decreasing intracranial pressure (ICP) found that HSL produced a significantly more profound and more prolonged decrease in ICP than mannitol. 13 However, the same study also showed a significant increase in blood glucose in patients receiving HSL. An increase in blood glucose to a certain limit is associated with detrimental effects on neurological outcome. 14, 15 This study aimed to compare the efficacy of HSL and mannitol in providing brain relaxation during craniectomy procedure in patients with moderate traumatic brain injury, as well as the effects of HSL and mannitol on hemodynamic parameters and blood glucose.
METHODS
Study approval was obtained from the Hasanuddin University Ethical Committee, letter number UH12110335. The study population were patients, aged 18 -65 years, presented with acute to moderate head injury within the first 48 hours, with Glasgow coma score (GCS) of 9 -13 and midline shift 5-10 mm, underwent craniectomy with opening of the duramater. Exclusion criteria was patients with trauma other than head injury, epidural hemorrhage, pregnant women, patients with (i) diabetes mellitus, (ii) history of untreated hypertension, (iii) initially hyponatremia (< 130 mmol/L), (iv) initially hypernatremia (> 155 mmol/L), (v) initially hyperglycemia (> 180 mg/dL), and (vi) initial Central venous pressures (CVP) < 8 mmHg.
Patients were randomly allocated to group M that received 20% mannitol, 2.5 mL. CVP and mean arterial pressures (MAP) were measured before infusion of osmotic solutions and at 15, 30, 45 and 60 minutes after infusion completed. Blood pressures were measured non-invasively. Blood glucose was measured before infusion and 60 minutes after the end of the infusion. Brain relaxation was assessed by the neurosurgeon immediately after the opening of the duramater, based on a four-point scale (1 = excellent, brain parechyma did not stick to the duramater; 2 = satisfactory, brain parenchyma stick to the duramater but still relaxed; 3 = firm, brain parenchym was tense, slightly bulged out; 4 = bulging, brain parenchyma protruded out of the duramater).
Fluid balance was maintained with normal saline and Ringer's Lactate with 3:1 ratio at a rate of 1.5 mL/kg/h. PaCO 2 was maintained at 35-40 mmHg using ETCO 2 . If the brain tension interfered the surgical manipulation, furosemide 20 mg or extra 20% mannitol 0.25 mg.kg -1 was given as rescue therapy. Hypotensive episodes, defined as 20% decrease in MAP from the baseline or systolic blood pressure < 90 mmHg, were treated with 5-10 mg ephedrine, followed by CVP measurement and 200 mL crystalloid bolus if CVP < 8 mmHg.
Categorical data were compared by chi-square test and Mann-Whitney test. Differences within the groups were evaluated using paired Student t test, and differences between the two groups were evaluated using unpaired Student-t test. A p value of ≤ 0.05 was considered significant. All numerical data are expressed as means ± SD.
RESULTS
Forty-two patients were included in the study, assigned by random envelope to M (n = 21) or HSL (n = 21) groups. The two groups were similar with respect to sex, age, GCS, ASA PS, midline shift, baseline MAP, CVP and blood glucose, as presented in table 1.
Significant differences ( p < 0.05) between the groups were found in the CVP at 30, 45, and 60 minutes where the CVP in group M was getting lower and lower and reached its lowest level after 60 minutes (7.87 ± 0.37 mmHg) while in group HSL the CVP tended to be stable with slight decrease, the lowest level after 60 minutes was 9.38 ± 0.37 mmHg ( Figure 1 ).
Diuresis was significantly higher (p = 1.001) after 30 minutes in group M and increasing about twice of the previous volume every 15 minutes. The volume of water loss through diuresis in group M was 2.35 X the group HSL after 60 minutes ( Table 2 ).
There was no difference in brain relaxation between the two groups, with three patients in group HSL and two patients in group M requiring rescue therapy for tense brain conditions.
Blood glucose level at 60 minutes was significantly higher in group HSL than in group M (141.81 ± 19.09 vs 122.71 ± 17.89, p = 0.027); the blood glucose difference in group HSL between baseline value and after 60 minutes was significant (17.95 ± 11.46, p = 0.001) ( Table 2) .
DISCUSSION
This study aimed to compare the effect of equiosmolar boluses of HSL and mannitol on clinical brain condition, hemodynamic variables (MAP and CVP) and blood glucose level in patients with moderate traumatic brain injury underwent craniectomy with opening of the duramater. The main findings were that during craniectomy, (1) either equiosmolar boluses of 2.5 mL.kg -1 20% mannitol or 0.5M hypertonic sodium lactate were both effective in providing brain relaxation in more than 75% cases; (2) 20% mannitol has more prominent diuretic effect than 0.5M HSL, resulted in more pronounced decrease in CVP and possibly 
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which is not in agreement with our finding (HSL has a similar sodium concentration to 3% HTS). The discrepancy could be due to differences in the volume of the hyperosmotic fluids administered to the patients and the populations studied.
The principal mechanism of action of hyperosmotic fluids such as HSL and mannitol is to create osmotic gradient across the blood-brain-barrier (BBB) due to impermeability of BBB to mannitol and sodium. [7] [8] but not to lactate. Therefore, the hyperosmotic property of HSL is derived from the sodium concentration in the solution, while lactate serves as the alternative energy source for the brain tissue, particularly in the post-ischemic condition. 12, 16 The effectiveness of the hyperosmotic fluid depends on the "reflection coefficient" of its solute, which determines the relative impermeability of BBB to the solute. A reflection coefficient of 1 means the BBB is absolutely impermeable to the solute, and 0 means totally permeable. The reflection coefficient of sodium is 1 and mannitol is 0.9, 7-8 therefore hypertonic solutions containing sodium may theoretically be superior to mannitol in reducing ICP or brain bulk. Unfortunately, the evidences are not yet enough to support this theory.
This study showed that HSL was associated with significantly less diuretic effect compared to mannitol, as was already reported by other studies. [7] [8] Rozet, et al 7 also reported a more negative fluid balance after mannitol administration and an increase in blood lactate over time, whereas no changes in blood lactate after HTS administration. The increase in lactate concentration may be secondary to effective hypovolemia induced by mannitol. Both 3% HTS and HSL have similar sodium concentration and cause an increase in serum sodium. 13 The increase in serum sodium stimulates the release of antidiuretic hormones, leading to the absorption of free water from the kidney, 17 which may explain the lower diuretic effect of HSL compared to mannitol. 8 We also found that mannitol was associated with a more significant decrease in CVP compared with HSL, possibly related to the diuretic effect of mannitol. We observed a significant increase in CVP at 15 minutes after HSL administration, which may be due to the volume expansion of the hyperosmotic solution, but the increase was not maintained. The same finding was also shown in a study by Gemma et al 18 after administration of 7.5% HTS.
In our study, MAP was more stable after HSL administration than mannitol. Blood pressure is determined by cardiac output and systemic vascular resistance. The determinants of cardiac output include stroke volume and heart rate; the stroke volume is determined by the preload volume and cardiac contractility. Assuming all other factors were comparable, the more negative fluid balance induced by mannitol may explain the more pronounced decrease in MAP.
Lactate was thought to increase the blood glucose due to hepatic gluconeogenesis (Cori cycle). 13 Patki, et al 19 showed that administration of Ringer Lactate 20 mL.kg -1 will increase the blood glucose level as much as 14.56 ± 0.51 mg.dL -1 , while Ichai, et al 13 showed 3.8% increase in blood glucose compared to baseline value after administration of 100 mL HSL.
In our current study, a significant increase in blood glucose level was seen in Group HSL which could be due to larger volume of HSL given to the patient, the surgical stress response, and the influence of isoflurane used during the procedure.
High level of blood glucose may have detrimental effect to the brain [14] [15] as was shown in a study by Lam, et al 14 that severe traumatic brain injury patients with post-operative blood glucose ≥ 200 mg.dL
had significantly worse outcome than those < 200 mg.dL -1 . Older theory stated that a high glucose level is detrimental in ischemic conditions because glucose will be converted to lactic acid, which causes neuronal damage. 20 However, more evidence have supported the newer theory proposed by Schurr, et al 21 that the detrimental effect of hyperglycemia during cerebral ischemia is not associated with lactate, but with the corticosterone released, in response to high glucose level. In contrast to post-ischemic conditions when the oxygen delivery has just started to resolve; lactate serves as a ready substrate, which can be directly converted to pyruvate. 12 Pyruvate then enters the tricarboxylic acid cycle to produce ATP, in which one lactate molecule yields 17 ATP.
Beside their hyperosmotic property, hyperosmolar fluids such as HSL, HTS and mannitol can improve the cerebral perfusion by their effects on blood rheology, shrinkage of erythrocytes, and the decreased CSF production. 8 Both HSL and mannitol also has antiinflammatory properties. mannitol has the free-radical scavenging property, which can reduce the increased malondialdehyde, catalase, and glutathione peroxidase in traumatic brain injury. 22 This effect is not owned by HSL. Whereas, HSL contains levo-lactate, that serves as a ready substrate for brain energy metabolism in post-ischemic conditions. mannitol does not have this advantage. Therefore, despite their osmotic properties, both HSL and mannitol have their own advantages in specific patient conditions. HSL is recommended for patients with suspected hypovolemia or hypoxia, while mannitol for cases with high baseline blood glucose, history of diabetes, or in hypernatremic conditions. Due to limited facilities, observation for patient outcome such as non-invasive measurement of blood pressure, ICP and arteriovenous difference of oxygen and lactate levels, were not performed.
In conclusion, 0.5M HSL was equivalently effective as 20% mannitol to produce brain relaxation. Administration of 2.5 mL.kg -1 0.5M HSL was associated with significant increase in blood glucose. To our knowledge, this is the first prospective, randomized human study comparing the effect of equiosmolar and equivolemic solutions of HSL and mannitol on intraoperative brain relaxation, blood pressure, CVP, and blood glucose level. HSL may be recommended as an alternative to mannitol for providing brain relaxation during craniectomy procedure in cases with moderate traumatic brain injury, unstable hemodynamic and/or when high risk of hypovolemia is expected and not for diabetic cases.
